Grants for State governments - Federal

The Federal and State Technology (FAST) Partnership Program provides funding to organizations to execute state/regional programs that increase the number of SBIR/STTR proposals leading to an increase in the number of SBIR/STTR awards from women, socially/economically disadvantaged individuals, and small businesses in underrepresented areas - typically rural states.

This grant provides funding to U.S. higher education institutions to support predoctoral training programs in neuroscience, focusing on developing a diverse group of skilled scientists through comprehensive research training and mentorship.

This funding opportunity provides financial support to Native American Tribes for projects aimed at reducing wildfire risks and enhancing community resilience against wildfires.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage current NCI U01 research projects to incorporate new technologies from the NCI Innovative Molecular Analysis Technologies program, in order to enhance their original research and speed up scientific discoveries in cancer research.

This funding opportunity provides financial support for the development of affordable and culturally appropriate biomedical technologies aimed at reducing healthcare disparities among underserved populations in the United States.

This grant provides funding and support for junior faculty from underrepresented backgrounds in neuroscience to lead independent clinical trials and advance their research careers.

The "Interaction Between Environmental Factors and Lewy Body Dementia" grant aims to fund research that investigates how environmental factors like pollution and metals can cause Lewy Body Dementia, with the goal of finding new, changeable targets for treatment.

This Notice identifies the draft criteria established for the selection of noise mitigation project(s) under the Community Noise Mitigation Program which is intended to facilitate the installation of sound insulation in covered facilities. Through the Consolidated Appropriations Act, 2022 (Pub. L. 117-103), $75 million in funding is available with $56,250,000 allocated for funding at or near active-duty military installations and $18,750,000 allocated for funding at or near guard or reserve installations, of which $5 million shall be for funding to communities for which a nearby military installation has transitioned to a new type or model of aircraft after January 1, 2019. The recipient has five (5) years from the date of award to expend these funds. The Office of Local Defense Community Cooperation must obligate these funds through a counter-signed grant agreement no later than TBD.

This funding opportunity provides financial support for U.S.-based organizations, including private companies, universities, and nonprofits, to advance the development of innovative fuel cell and electrolysis technologies for efficient hydrogen production.

The grant titled "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)" is designed to fund exploratory research projects that use innovative methods to understand how brain circuit activity influences mental experiences and behavior, with successful results potentially leading to further research projects.

This grant provides funding to state agencies to create or revive coordinated respite care systems that support family caregivers of individuals with disabilities or chronic conditions across all ages.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

This program provides funding to state law enforcement agencies to enhance their efforts in combating heroin and opioid trafficking through collaborative investigations and improved resources.

This cooperative agreement is designed to enable the Maryland Technology Development Corporation to facilitate the transfer and commercialization of technologies that support the U.S. Army's chemical and biological defense needs.

This funding opportunity supports innovative and high-risk neuroscience research projects that may lack extensive preliminary data, aimed at advancing our understanding of neurological and mental health disorders.

This grant provides funding to support early-career researchers from diverse backgrounds in developing independent careers focused on Alzheimer's disease and related dementias through mentored training and research opportunities.

This funding opportunity provides financial support to higher education institutions and training programs to develop a diverse and well-trained behavioral health workforce focused on serving children, adolescents, and young adults in underserved communities.

This funding opportunity provides financial support to nonprofit organizations that offer emergency shelter and services for youth under 18 who are homeless or have run away from home, helping them stabilize their situations and work towards family reunification.

This funding opportunity supports research using advanced laboratory models to investigate how HIV and various addictive substances interact to affect brain health and neurological disorders.

This funding opportunity supports researchers working on developing and optimizing genome editing therapies for various forms of Alzheimer's Disease-Related Dementias, aiming to advance these treatments towards clinical use.